Clinical Trials
12 trialsNCT03143270 2026-05-07
A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07295262 2025-12-19
NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
West China Hospital
Phase EARLY_PHASE1 Recruiting
NCT07106814 2025-09-15
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT06173726 2023-12-18
Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05860374 2023-05-16
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT04150874 2023-04-10
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Terminated
NCT03891654 2022-05-02
Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT04951141 2021-07-06
Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03888859 2021-03-29
ET1402L1-ARTEMISâ„¢2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1 Completed
NCT03965546 2019-08-08
ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1 Unknown
NCT00436410 2012-05-02
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed